甲狀旁腺腫瘤及增生的臨床病理學研究進展
本文關(guān)鍵詞:甲狀旁腺腫瘤及增生的臨床病理學研究進展,由筆耕文化傳播整理發(fā)布。
甲狀旁腺腫瘤及增生的臨床病理學研究進展
摘要:組織病理學檢查能確定甲狀旁腺亢進癥的病理類型,是鑒別甲狀旁腺增生、甲狀旁腺腺瘤和甲狀旁腺癌的經(jīng)典方法。近年來,甲狀旁腺腫瘤及增生的免疫組織化學標記、分子病理學研究進展迅速,研究包括Cyc lin D1,MEN1,HRPT2和CaSR基因與蛋白。臨床影像學技術(shù)的發(fā)展使甲狀旁腺疾病的術(shù)前診斷更為準確,術(shù)中測定的甲狀旁腺激素水平可作為評估手術(shù)療效的指標。
Histopathological examination can determine the pathological types of hyperparathyroidism,which is a classical method to differentiate among parathyroid hyperplasia,parathyroid adenoma and parathyroid carcinoma.In recent years,there has been rapid progress in research of immunohistochemical labelling and molecular pathology of parathyroid tumors and hyperplasia,including Cyclin D1,MEN1,HRPT2 and CaSR gene and protein.The development of clinical imaging techniques makes the preoperative diagnosis of parathyroid diseases more accurate,and the parathyroid hormone levels measured during operation may serve as parameters for evaluation of surgical outcomes.
本文關(guān)鍵詞:甲狀旁腺腫瘤及增生的臨床病理學研究進展,由筆耕文化傳播整理發(fā)布。
,本文編號:127739
本文鏈接:http://sikaile.net/yixuelunwen/binglixuelunwen/127739.html